IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, presenting promising enhancements across several clinical and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA presents a safer, far more reliable alternate for therapeutic us